Academic Frontier
Bioactive Materials | The amino-nanoparticle platform based on fullerenes enables a synergistic effect in VEGFR2-targeted anti-angiogenic and tumor immunotherapy.
QQ Academic Group: 1092348845
Detailed
Rational angiogenesis and immunosuppression limit the efficacy of cancer treatment. This pape
- Previous： ACS Nano | Cell Nanopa
- Next： Nature Communications
